Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Prometheus Biosciences (RXDX) - Total debt
Total debt on the balance sheet as of March 2023 : $29.46 M
According to Prometheus Biosciences's latest financial reports the company's total debt is $29.46 M. A company’s total debt is the sum of all current and non-current debts.
Prometheus Biosciences - Total debt on balance sheet (from 2020 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $29.53 M | |
| 2020-12-31 | $7.39 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | N/A | N/A | 🇺🇸 USA |
 Akebia Therapeutics AKBA | $82.87 M | 181.28% | 🇺🇸 USA |
 Agenus
AGEN | $87.34 M | 196.46% | 🇺🇸 USA |